fluorodeoxyglucose f18 has been researched along with Encephalitis Lethargica Type Parkinsonism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T | 1 |
| Georgiou, M; Lopez-Alberola, R; Papapetropoulos, S; Sfakianakis, GN; Singer, C | 1 |
| Bamborschke, S; Ghaemi, M; Heiss, WD; Rudolf, J; Schmülling, S | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Encephalitis Lethargica Type Parkinsonism
| Article | Year |
|---|---|
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes.
Topics: Adolescent; Adult; Antibodies; Basal Ganglia; Blotting, Western; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Leukocytosis; Magnetic Resonance Imaging; Male; Parkinson Disease, Postencephalitic; Positron-Emission Tomography; Thalamus; Treatment Outcome; Young Adult | 2009 |
FDG- and Dopa-PET in postencephalitic parkinsonism.
Topics: Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Parkinson Disease, Postencephalitic; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2000 |